287 related articles for article (PubMed ID: 12212809)
1. Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.
Weber D; Berger C; Heinrich T; Eickelmann P; Antel J; Kessler H
J Pept Sci; 2002 Aug; 8(8):461-75. PubMed ID: 12212809
[TBL] [Abstract][Full Text] [Related]
2. Discovery of high affinity bombesin receptor subtype 3 agonists.
Wu JM; Nitecki DE; Biancalana S; Feldman RI
Mol Pharmacol; 1996 Nov; 50(5):1355-63. PubMed ID: 8913368
[TBL] [Abstract][Full Text] [Related]
3. Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3.
Mantey SA; Coy DH; Entsuah LK; Jensen RT
J Pharmacol Exp Ther; 2004 Sep; 310(3):1161-70. PubMed ID: 15102928
[TBL] [Abstract][Full Text] [Related]
4. The design of a new potent and selective ligand for the orphan bombesin receptor subtype 3 (BRS3).
Boyle RG; Humphries J; Mitchell T; Showell GA; Apaya R; Iijima H; Shimada H; Arai T; Ueno H; Usui Y; Sakaki T; Wada E; Wada K
J Pept Sci; 2005 Mar; 11(3):136-41. PubMed ID: 15635635
[TBL] [Abstract][Full Text] [Related]
5. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
[TBL] [Abstract][Full Text] [Related]
6. Discovery of potent and selective peptide agonists at the GRP-preferring bombesin receptor (BB2).
Darker JG; Brough SJ; Heath J; Smart D
J Pept Sci; 2001 Nov; 7(11):598-605. PubMed ID: 11763364
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology and cell biology of the bombesin receptor subtype 4 (BB4-R).
Katsuno T; Pradhan TK; Ryan RR; Mantey SA; Hou W; Donohue PJ; Akeson MA; Spindel ER; Battey JF; Coy DH; Jensen RT
Biochemistry; 1999 Jun; 38(22):7307-20. PubMed ID: 10353842
[TBL] [Abstract][Full Text] [Related]
8. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs.
Wu JM; Hoang DO; Feldman RI
Mol Pharmacol; 1995 Apr; 47(4):871-81. PubMed ID: 7723750
[TBL] [Abstract][Full Text] [Related]
9. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
Lin JT; Coy DH; Mantey SA; Jensen RT
J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
[TBL] [Abstract][Full Text] [Related]
10. Two amino acids in the sixth transmembrane segment of the mouse gastrin-releasing peptide receptor are important for receptor activation.
Lin Y; Jian X; Lin Z; Kroog GS; Mantey S; Jensen RT; Battey J; Northup J
J Pharmacol Exp Ther; 2000 Sep; 294(3):1053-62. PubMed ID: 10945859
[TBL] [Abstract][Full Text] [Related]
11. Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP).
Nakagawa T; Hocart SJ; Schumann M; Tapia JA; Mantey SA; Coy DH; Tokita K; Katsuno T; Jensen RT
Biochem Pharmacol; 2005 Feb; 69(4):579-93. PubMed ID: 15670577
[TBL] [Abstract][Full Text] [Related]
12. Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: analysis of binding, kinetics, stoichiometry, modulation by guanine nucleotide-binding proteins, and signal transduction and comparison with natively expressed receptors.
Benya RV; Wada E; Battey JF; Fathi Z; Wang LH; Mantey SA; Coy DH; Jensen RT
Mol Pharmacol; 1992 Dec; 42(6):1058-68. PubMed ID: 1336112
[TBL] [Abstract][Full Text] [Related]
13. Expression and characterization of cloned human bombesin receptors.
Benya RV; Kusui T; Pradhan TK; Battey JF; Jensen RT
Mol Pharmacol; 1995 Jan; 47(1):10-20. PubMed ID: 7838118
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology and intracellular signaling mechanisms of the native human orphan receptor BRS-3 in lung cancer cells.
Ryan RR; Weber HC; Mantey SA; Hou W; Hilburger ME; Pradhan TK; Coy DH; Jensen RT
J Pharmacol Exp Ther; 1998 Oct; 287(1):366-80. PubMed ID: 9765358
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for agonism in the BB3 receptor: an epitope located on the interface of transmembrane-III, -VI, and -VII.
Gbahou F; Holst B; Schwartz TW
J Pharmacol Exp Ther; 2010 Apr; 333(1):51-9. PubMed ID: 20065020
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a novel class of neuromedin B receptor antagonists, substituted somatostatin analogues.
Orbuch M; Taylor JE; Coy DH; Mrozinski JE; Mantey SA; Battey JF; Moreau JP; Jensen RT
Mol Pharmacol; 1993 Oct; 44(4):841-50. PubMed ID: 7901752
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor.
Gonzalez N; Hocart SJ; Portal-Nuñez S; Mantey SA; Nakagawa T; Zudaire E; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2008 Feb; 324(2):463-74. PubMed ID: 18006692
[TBL] [Abstract][Full Text] [Related]
18. Design of selective peptidomimetic agonists for the human orphan receptor BRS-3.
Weber D; Berger C; Eickelmann P; Antel J; Kessler H
J Med Chem; 2003 May; 46(10):1918-30. PubMed ID: 12723954
[TBL] [Abstract][Full Text] [Related]
19. Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes.
Mantey S; Frucht H; Coy DH; Jensen RT
Mol Pharmacol; 1993 May; 43(5):762-74. PubMed ID: 7684815
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors.
Mantey SA; Weber HC; Sainz E; Akeson M; Ryan RR; Pradhan TK; Searles RP; Spindel ER; Battey JF; Coy DH; Jensen RT
J Biol Chem; 1997 Oct; 272(41):26062-71. PubMed ID: 9325344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]